SUBSCribe
logo
twitterlinkedininstagramUser Profile
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?

          Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh

          V Keshavdev - December 10, 2020
        • A Growing Appetite

          Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market

          Krishna Gopalan - November 28, 2017
        • At Home With Art

          Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art

          Krishna Gopalan - August 19, 2017
        • Under The Weather- Part 1

          The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home

          Krishna Gopalan - May 20, 2017
        • Under The Weather - Part 2

          Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home

          Krishna Gopalan - June 05, 2017
        • Managing Growth 2017- Part 2

          Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal

          March 17, 2017
        • Managing Growth 2017- Part 1

          CEOs from diverse sectors on what's in store for 2017

          March 17, 2017
        • Growth eclipse

          After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?

          Krishna Gopalan - January 22, 2016
        • Cash-rich picks in the current market

          Looking for cash bargains? Here is a first cut list

          Jitendra Kumar Gupta - August 26, 2015
        • Dilip Shanghvi

          The Sun Pharma founder is a man of few words and the perfect dose of calm and strength

          Krishna Gopalan - July 02, 2015